FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elke de Jong

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
A G M Hendriks; R R M C Keijsers; M M B Seyger; Elke M G J de Jong; P C M van de Kerkhof
Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review.
Paula P M van Lümig; Jan B M Boezeman; Rieke J B Driessen; W Kievit; Peter C M van de Kerkhof; Elke M G J de Jong
Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practice.
A M Oostveen; M E A de Jager; Elke M G J de Jong; A R T Donders; P C M van de Kerkhof; M M B Seyger
The influence of treatments in daily clinical practice on the Children's Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elke de Jong (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: A G M Hendriks; R R M C Keijsers; M M B Seyger; Elke M G J de Jong; P C M van de Kerkhof
Combinations of classical time-honoured topicals in plaque psoriasis: a systematic review.
Journal of the European Academy of Dermatology and Venereology : JEADV 2013;27(4):399-410.
2013: Paula P M van Lümig; Jan B M Boezeman; Rieke J B Driessen; W Kievit; Peter C M van de Kerkhof; Elke M G J de Jong
Results of three analytical approaches on long-term efficacy of etanercept for psoriasis in daily practice.
Journal of the American Academy of Dermatology 2013;68(1):57-63.
2012: A M Oostveen; M E A de Jager; Elke M G J de Jong; A R T Donders; P C M van de Kerkhof; M M B Seyger
The influence of treatments in daily clinical practice on the Children's Dermatology Life Quality Index in juvenile psoriasis: a longitudinal study from the Child-CAPTURE patient registry.
The British journal of dermatology 2012;167(1):145-9.
2012: P P M van Lümig; Maartje A M Berends; Jan B M Boezeman; R J B Driessen; P C M van de Kerkhof; Elke M G J de Jong
Safety of treatment with biologics for psoriasis in daily practice: 5-year data.
Journal of the European Academy of Dermatology and Venereology : JEADV 2012;26(3):283-91.
2011: Michelle E A de Jager; Elke M G J de Jong; Andrea W M Evers; Peter C M Van De Kerkhof; M M B Seyger
The burden of childhood psoriasis.
Pediatric dermatology 2011;28(6):736-7.
2011: P P M van Lümig; Jan B M Boezeman; R J B Driessen; M A M A Roelofs-Thijssen; P C M van de Kerkhof; Elke M G J de Jong
Relevance of laboratory investigations in monitoring patients with psoriasis on etanercept or adalimumab.
The British journal of dermatology 2011;165(2):375-82.
2011: M E A de Jager; Elke M G J de Jong; A W M Evers; P C M van de Kerkhof; M M B Seyger
An intrapatient comparison of quality of life in psoriasis in childhood and adulthood.
Journal of the European Academy of Dermatology and Venereology : JEADV 2011;25(7):828-31.
2011: L Y T Chiam; M E A de Jager; Y C Giam; Elke M G J de Jong; P C M van de Kerkhof; M M B Seyger
Juvenile psoriasis in European and Asian children: similarities and differences.
The British journal of dermatology 2011;164(5):1101-3.
2011: Hilbert S de Vries; Martijn G H Van Oijen; Rieke J B Driessen; Elke M G J de Jong; Marjonne C W Creemers; W Kievit; Dirk J de Jong
Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists.
British journal of clinical pharmacology 2011;71(1):7-19.
2010: Andrea W M Evers; E W M Verhoeven; Floris W Kraaimaat; Elke M G J de Jong; S J M de Brouwer; Joost Schalkwijk; F C G J Sweep; P C M van de Kerkhof
How stress gets under the skin: cortisol and stress reactivity in psoriasis.
The British journal of dermatology 2010;163(5):986-91.
2010: M E A de Jager; P C M van de Kerkhof; Elke M G J de Jong; M M B Seyger
A cross-sectional study using the Children's Dermatology Life Quality Index (CDLQI) in childhood psoriasis: negative effect on quality of life and moderate correlation of CDLQI with severity scores.
The British journal of dermatology 2010;163(5):1099-101.
2010: P P M Van Lümig; L L A Lecluse; R J B Driessen; Phyllis I Spuls; Jan B M Boezeman; P C M van de Kerkhof; Elke M G J de Jong
Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept.
The British journal of dermatology 2010;163(4):838-46.
2010: R J B Driessen; L A Bisschops; E M M Adang; Andrea W M Evers; P C M van de Kerkhof; Elke M G J de Jong
The economic impact of high-need psoriasis in daily clinical practice before and after the introduction of biologics.
The British journal of dermatology 2010;162(6):1324-9.
2010: Michelle E A de Jager; Elke M G J de Jong; Peter C M van de Kerkhof; M M B Seyger
Efficacy and safety of treatments for childhood psoriasis: a systematic literature review.
Journal of the American Academy of Dermatology 2010;62(6):1013-30.
2010: Rieke J B Driessen; Elke M G J de Jong; Gerrit W Salemink; Jan H G Bürer; Peter C M van de Kerkhof; Frank H J van den Hoogen
Analysis of 4-year Dutch reimbursement application data of biological therapies for psoriatic arthritis.
Rheumatology (Oxford, England) 2010;49(3):588-91.
2010: Lidian L A Lecluse; Rieke J B Driessen; Phyllis I Spuls; Elke M G J de Jong; Steven O Stapel; Martijn B A van Doorn; Jan D Bos; Gert-Jan Wolbink
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.
Archives of dermatology 2010;146(2):127-32.
2010: M E A de Jager; P C M van de Kerkhof; Elke M G J de Jong; M M B Seyger
Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion.
Dermatology (Basel, Switzerland) 2010;220(4):329-32.
2009: Elisabeth B M Kroft; Elke M G J de Jong; Andrea W M Evers
Psychological distress in patients with morphea and eosinophilic fasciitis.
Archives of dermatology 2009;145(9):1017-22.
2009: E W M Verhoeven; Floris W Kraaimaat; Elke M G J de Jong; Joost Schalkwijk; P C M van de Kerkhof; Andrea W M Evers
Individual differences in the effect of daily stressors on psoriasis: a prospective study.
The British journal of dermatology 2009;161(2):295-9.
2009: Heidi V N Küsters-Vandevelde; Maurits N C de Koning; Willem J G Melchers; Wim G V Quint; Peter C M de Wilde; Elke M G J de Jong; Peter C M van de Kerkhof; Willeke A M Blokx
Expression of p14ARF, p16INK4a and p53 in relation to HPV in (pre-)malignant squamous skin tumours.
Journal of cellular and molecular medicine 2009;13(8B):2148-57.
2009: E B M Kroft; M C W Creemers; F H J van den Hoogen; Jan B M Boezeman; Elke M G J de Jong
Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
The British journal of dermatology 2009;160(5):1075-82.
2009: Angelina Erceg; H Jorn Bovenschen; Peter C M van de Kerkhof; Elke M G J de Jong; M M B Seyger
Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus.
Journal of the American Academy of Dermatology 2009;60(4):626-32.
2009: Rosanne G van Lingen; Piet E J van Erp; Marieke M B Seyger; Elke M G J de Jong; Roelie T de Boer-van Huizen; Rieke J B Driessen; Peter C M van de Kerkhof
Persistent expression of CD26/DPPIV after treatment with infliximab in psoriasis despite clinical improvement.
Acta dermato-venereologica 2009;89(5):518-20.
2009: Michelle E A De Jager; Peter C M Van de Kerkhof; Elke M G J de Jong; M M B Seyger
Epidemiology and prescribed treatments in childhood psoriasis: a survey among medical professionals.
The Journal of dermatological treatment 2009;20(5):254-8.
2009: Elisabeth B M Kroft; Tamara J Groeneveld; M M B Seyger; Elke M G J de Jong
Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study.
American journal of clinical dermatology 2009;10(3):181-7.
2009: Patrick A M Jansen; Diana Rodijk-Olthuis; Edward J Hollox; Marijke Kamsteeg; Geuranne S Tjabringa; Gys J de Jongh; Ivonne M J J van Vlijmen-Willems; Judith G M Bergboer; Michelle M van Rossum; Elke M G J de Jong; Martin den Heijer; Andrea W M Evers; Mieke Bergers; John A L Armour; Patrick L J M Zeeuwen; Joost Schalkwijk
Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skin.
PloS one 2009;4(3):e4725.
2009: Andrea W M Evers; Piet Duller; Elke M G J de Jong; Marisol E Otero; Chris Verhaak; P G M van der Valk; Peter C M van de Kerkhof; Floris W Kraaimaat
Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis.
Acta dermato-venereologica 2009;89(1):57-63.
2009: Else N Kop; John E M Körver; Delphine Van Ruysevelt; Elke M G J de Jong; P G M van der Valk; Peter C M Van de Kerkhof
Erythroderma in two patients with psoriasis upon discontinuation of efalizumab treatment.
The Journal of dermatological treatment 2009;20(1):67-9.
2009: Rieke J B Driessen; Jan B M Boezeman; Peter C M Van De Kerkhof; Elke M G J de Jong
Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
The Journal of dermatological treatment 2009;20(1):42-7.
2009: Angelina Erceg; Elke M G J de Jong; Rosanne G Van Lingen; Theo M de Boo; Peter C M Van De Kerkhof; M M B Seyger
Validation of clinical and image skin scoring systems for a single chronic discoid lupus erythematosus lesion.
The Journal of dermatological treatment 2009;20(1):32-5.
2008: Elisabeth B M Kroft; Nadine J G Berkhof; Peter C M van de Kerkhof; Rianne M J P Gerritsen; Elke M G J de Jong
Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review.
Journal of the American Academy of Dermatology 2008;59(6):1017-30.
2008: Rosanne G van Lingen; Elke M G J de Jong; Piet E J van Erp; Wilmy S E C van Meeteren; Peter C M van De Kerkhof; M M B Seyger
Nd: YAG laser (1,064 nm) fails to improve localized plaque type psoriasis: a clinical and immunohistochemical pilot study.
European journal of dermatology : EJD 2008;18(6):671-6.
2008: R G van Lingen; M K P Poll; M M B Seyger; Elke M G J de Jong; P C M van de Kerkhof; Piet E J van Erp
Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers.
Archives of dermatological research 2008;300(10):561-7.
2008: Elisabeth B M Kroft; Elke M G J de Jong; Andrea W M Evers
Physical burden of symptoms in patients with localized scleroderma and eosinophilic fasciitis.
Archives of dermatology 2008;144(10):1394-5.
2008: R J B Driessen; P C M van de Kerkhof; Elke M G J de Jong
Etanercept combined with methotrexate for high-need psoriasis.
The British journal of dermatology 2008;159(2):460-3.
2008: Elisabeth B M Kroft; Elke M G J de Jong
Scleredema diabeticorum case series: successful treatment with UV-A1.
Archives of dermatology 2008;144(7):947-8.
2008: R G van Lingen; J E M Körver; P C M van de Kerkhof; Maartje A M Berends; D W A van Rens; Annechien M G Langewouters; Jan B M Boezeman; M M B Seyger; Elke M G J de Jong
Relevance of compartmentalization of T-cell subsets for clinical improvement in psoriasis: effect of immune-targeted antipsoriatic therapies.
The British journal of dermatology 2008;159(1):91-6.
2008: E B M Kroft; P C M van de Kerkhof; M J P Gerritsen; Elke M G J de Jong
Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
Journal of the European Academy of Dermatology and Venereology : JEADV 2008;22(7):839-44.
2008: R G van Lingen; P C M van de Kerkhof; M M B Seyger; Elke M G J de Jong; D W A van Rens; M K P Poll; Patrick L J M Zeeuwen; Piet E J van Erp
CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
The British journal of dermatology 2008;158(6):1264-72.
2008: R J B Driessen; M A M Berends; Jan B M Boezeman; P C M van de Kerkhof; Elke M G J de Jong
Psoriasis treatment with etanercept and efalizumab: clinical strategies influencing treatment outcome.
The British journal of dermatology 2008;158(5):1098-106.
2008: Rosanne G van Lingen; Peter C M van de Kerkhof; Elke M G J de Jong; M M B Seyger; Jan B M Boezeman; Piet E J van Erp
Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients.
Experimental dermatology 2008;17(4):343-8.
2008: W H P M Vissers; I van Vlijmen; Piet E J van Erp; Elke M G J de Jong; P C M van de Kerkhof
Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
The British journal of dermatology 2008;158(4):705-12.
2008: Annechien M G Langewouters; Piet E J van Erp; Elke M G J de Jong; P C M van de Kerkhof
Lymphocyte subsets in peripheral blood of patients with moderate-to-severe versus mild plaque psoriasis.
Archives of dermatological research 2008;300(3):107-13.
2008: Rosanne G van Lingen; Elke M G J de Jong; Maartje A M Berends; M M B Seyger; Piet E J van Erp; Peter C M van de Kerkhof
Good clinical response to anti-psoriatic treatment with adalimumab and methotrexate does not inflict a direct effect on compartmentalization of T-cell subsets: a pilot study.
The Journal of dermatological treatment 2008;19(5):284-7.
2008: W H P M Vissers; Mirella W F M van Duijnhoven; Piet E J van Erp; Elke M G J de Jong; P C M van de Kerkhof
The effect of alefacept on T-cell subsets and cells expressing NK receptors in lesional psoriatic skin: the effects of monotherapy and combination treatment with calcipotriol.
The Journal of dermatological treatment 2008;19(6):344-50.
2008: Elisabeth W M Verhoeven; Suzanne de Klerk; Floris W Kraaimaat; Peter C M van de Kerkhof; Elke M G J de Jong; Andrea W M Evers
Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review.
Acta dermato-venereologica 2008;88(3):211-8.
2008: Andrea W M Evers; Piet Duller; P C M van de Kerkhof; P G M van der Valk; Elke M G J de Jong; M J P Gerritsen; E Otero; E W M Verhoeven; Chris Verhaak; Floris W Kraaimaat
The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument.
The British journal of dermatology 2008;158(1):101-8.
2007: Maartje A M Berends; Martijn G H Van Oijen; Josje Snoek; P C M van de Kerkhof; Joost P H Drenth; J Han van Krieken; Elke M G J de Jong
Reliability of the Roenigk classification of liver damage after methotrexate treatment for psoriasis: a clinicopathologic study of 160 liver biopsy specimens.
Archives of dermatology 2007;143(12):1515-9.
2007: Maartje A M Berends; Josje Snoek; Elke M G J de Jong; J H J M van Krieken; Robert J de Knegt; Martijn G H Van Oijen; P C M van de Kerkhof; Joost P H Drenth
Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(5):639-45.
2007: H Jorn Bovenschen; Wil-Janne Gerritsen; D W A van Rens; M M B Seyger; Elke M G J de Jong; P C M van de Kerkhof
Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Archives of dermatological research 2007;298(9):457-63.
2007: Annechien M G Langewouters; H Jorn Bovenschen; Elke M G J de Jong; Piet E J van Erp; P C M van de Kerkhof
The effect of topical corticosteroids in combination with alefacept on circulating T-cell subsets in psoriasis.
The Journal of dermatological treatment 2007;18(5):279-85.
2007: Maartje A M Berends; Elke M G J de Jong; P C M van de Kerkhof; M J P Gerritsen
Dermatologists' adherence to the guideline of the Dutch Society of Dermatology and Venereology with respect to the treatment with methotrexate for severe chronic plaque psoriasis: results from a Dutch survey.
Dermatology (Basel, Switzerland) 2007;215(1):45-52.
2007: Maartje A M Berends; Rieke J B Driessen; Annechien M G Langewouters; Jan B M Boezeman; P C M van de Kerkhof; Elke M G J de Jong
Etanercept and efalizumab treatment for high-need psoriasis. Effects and side effects in a prospective cohort study in outpatient clinical practice.
The Journal of dermatological treatment 2007;18(2):76-83.
2006: Maartje A M Berends; Josje Snoek; Elke M G J de Jong; P C M van de Kerkhof; Martijn G H Van Oijen; J H J M van Krieken; Joost P H Drenth
Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent.
Alimentary pharmacology & therapeutics 2006;24(5):805-11.
2006: Annechien M G Langewouters; Piet E J van Erp; Elke M G J de Jong; P C M van de Kerkhof
The added therapeutic efficacy and safety of alefacept in combination with other (systemic) anti-psoriatics in refractory psoriasis.
The Journal of dermatological treatment 2006;17(6):362-9.
2006: P C M van de Kerkhof; Marloes M Kleinpenning; Elke M G J de Jong; M J P Gerritsen; Rens J van Dooren-Greebe; Hans A C Alkemade
Current and future treatment options for acne.
The Journal of dermatological treatment 2006;17(4):198-204.
2006: H Jorn Bovenschen; Wil-Janne Gerritsen; Elke M G J de Jong; P C M van de Kerkhof
Addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis.
Acta dermato-venereologica 2006;86(3):281-2.
2005: Mirella W F M van Duijnhoven; Elke M G J de Jong; W J Gerritsen; Marcel C Pasch; P C M van de Kerkhof
Alefacept modifies long-term disease severity and improves the response to other treatments.
European journal of dermatology : EJD 2005;15(5):366-73.
2005: Marcel Flendrie; W H P M Vissers; M C W Creemers; Elke M G J de Jong; P C M van de Kerkhof; P L C M van Riel
Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study.
Arthritis research & therapy 2005;7(3):R666-76.
2005: W H P M Vissers; J Roelofzen; Elke M G J de Jong; Piet E J van Erp; P C M van de Kerkhof
Flexural versus plaque lesions in psoriasis: an immunohistochemical differentiation.
European journal of dermatology : EJD 2005;15(1):13-7.
2005: Willeke A M Blokx; Dirk J Ruiter; Marian A J Verdijk; Peter C M de Wilde; Riki W Willems; Elke M G J de Jong; M J L Ligtenberg
INK4-ARF and p53 mutations in metastatic cutaneous squamous cell carcinoma: case report and archival study on the use of Ink4a-ARF and p53 mutation analysis in identification of the corresponding primary tumor.
The American journal of surgical pathology 2005;29(1):125-30.
2004: Jürgen V Smit; Elke M G J de Jong; Candida A E M van Hooijdonk; Marisol E Otero; Jan B M Boezeman; P C M van de Kerkhof
Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin.
Journal of the American Academy of Dermatology 2004;51(2):257-64.
2004: Jürgen V Smit; Manon E J Franssen; Elke M G J de Jong; Julien Lambert; Diane Roseeuw; Jozef De Weert; Richard C Yocum; Victor J. Stevens; P C M van de Kerkhof
A phase II multicenter clinical trial of systemic bexarotene in psoriasis.
Journal of the American Academy of Dermatology 2004;51(2):249-56.
2004: W H P M Vissers; Leon Muys; P E J Van Erp; Elke M G J de Jong; P C M van de Kerkhof
Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis.
European journal of dermatology : EJD 2004;14(4):216-20.
2004: W H P M Vissers; C H M Arndtz; Leon Muys; Piet E J van Erp; Elke M G J de Jong; P C M van de Kerkhof
Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late.
The British journal of dermatology 2004;150(5):852-9.
2004: W H P M Vissers; Maartje A M Berends; Leon Muys; Piet E J van Erp; Elke M G J de Jong; P C M van de Kerkhof
The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
Experimental dermatology 2004;13(2):106-12.
2004: Jürgen V Smit; Ruud G L de Sévaux; Willeke A M Blokx; P C M van de Kerkhof; Andries J Hoitsma; Elke M G J de Jong
Acitretin treatment in (pre)malignant skin disorders of renal transplant recipients: Histologic and immunohistochemical effects.
Journal of the American Academy of Dermatology 2004;50(2):189-96.
2003: Willeke A M Blokx; Elke M G J de Jong; Peter C M de Wilde; Johan Bulten; Monique M G M Link; Dirk J Ruiter; P C M van de Kerkhof
P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(9):869-78.
2003: Ruud G L de Sévaux; Jürgen V Smit; Elke M G J de Jong; P C M van de Kerkhof; Andries J Hoitsma
Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin.
Journal of the American Academy of Dermatology 2003;49(3):407-12.
2003: Jürgen V Smit; Elke M G J de Jong; P C M van de Kerkhof
Effects of oral bexarotene (targretin) on the minimal erythema dose for broadspectrum UVB light.
Skin pharmacology and applied skin physiology 2003;16(4):237-41.
2003: Willeke A M Blokx; Jürgen V Smit; Peter C M de Wilde; P C M van de Kerkhof; Dirk J Ruiter; Elke M G J de Jong
Immunohistochemical effects of temporary cessation of long-term acitretin treatment in keratinocytic intraepidermal neoplasia of renal transplant recipients.
Archives of dermatology 2003;139(5):671-3.
2003: Cecile Grootscholten; Mieke C J van Bruggen; Johan W van der Pijl; Elke M G J de Jong; Gerry Ligtenberg; R H W M Derksen; Jo H M Berden
Deposition of nucleosomal antigens (histones and DNA) in the epidermal basement membrane in human lupus nephritis.
Arthritis and rheumatism 2003;48(5):1355-62.
2003: Elke M G J de Jong; N J Mørk; M M B Seijger; M de La Brassine; J Lauharanta; C T Jansen; Jean-Jacques Guilhou; B Guillot; A Ostrojic; P Souteyrand; L Vaillant; L Barnes; S Rogers; M R Klaber; P C M van de Kerkhof
The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial.
The British journal of dermatology 2003;148(2):318-25.
2002: Jürgen V Smit; S Cox; Willeke A M Blokx; P C M van de Kerhof; G J de Jongh; Elke M G J de Jong
Actinic keratoses in renal transplant recipients do not improve with calcipotriol cream and all-trans retinoic acid cream as monotherapies or in combination during a 6-week treatment period.
The British journal of dermatology 2002;147(4):816-8.
2002: Willeke A M Blokx; Jürgen V Smit; Elke M G J de Jong; Monique M G M Link; P C M van de Kerkhof; Dirk J Ruiter
Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients.
Archives of dermatology 2002;138(1):61-5.
2001: M M B Seyger; FH van den Hoogen; Ivonne M J J van Vlijmen-Willems; P C M van de Kerkhof; Elke M G J de Jong
Localized and systemic scleroderma show different histological responses to methotrexate therapy.
The Journal of pathology 2001;193(4):511-6.
2000: Jürgen V Smit; Elke M G J de Jong; G J de Jongh; P C M van de Kerkhof
Topical all-trans retinoic acid does not influence minimal erythema doses for UVB light in normal skin.
Acta dermato-venereologica 2000;80(1):66-7.
1999: C J M van der Vleuten; Ivonne M J J van Vlijmen-Willems; Elke M G J de Jong; P C M van de Kerkhof
Clobetasol-17 propionate lotion under hydrocolloid dressing (Duoderm ET) once weekly versus unoccluded clobetasol-17-propionate ointment twice daily in psoriasis: an immunohistochemical study on remission and relapse.
Archives of dermatological research 1999;291(7-8):390-5.
1999: Elke M G J de Jong; HE Menke; MC Van Praag; P C M van de Kerkhof
Dystrophic psoriatic fingernails treated with 1% 5-fluorouracil in a nail penetration-enhancing vehicle: a double-blind study.
Dermatology (Basel, Switzerland) 1999;199(4):313-8.
1999: M M B Seyger; F H van den Hoogen; S de Mare; U van Haelst; Elke M G J de Jong
A patient with a severe scleroedema diabeticorum, partially responding to low-dose methotrexate.
Dermatology (Basel, Switzerland) 1999;198(2):177-9.
1998: M M B Seyger; Mieke C J van Bruggen; H K Hardeman; FH van den Hoogen; Jo H M Berden; Jacob Van Den Born; Elke M G J de Jong
Decreased staining of heparan sulfate in non-lesional skin of a subgroup of patients with systemic lupus erythematosus.
Acta dermato-venereologica 1998;78(5):326-30.
1998: JP van Pelt; Elke M G J de Jong; M M Seijger; Candida A E M van Hooijdonk; ES de Bakker; I M Van Vlijmen; G L Parker; Piet E J van Erp; P C M van de Kerkhof
Investigation on a novel and specific leukotriene B4 receptor antagonist in the treatment of stable plaque psoriasis.
The British journal of dermatology 1998;139(3):396-402.
1998: M M B Seyger; FH van den Hoogen; T de Boo; Elke M G J de Jong
Low-dose methotrexate in the treatment of widespread morphea.
Journal of the American Academy of Dermatology 1998;39(2 Pt 1):220-5.
1998: M M B Seyger; P C M van de Kerkhof; Ivonne M J J van Vlijmen-Willems; ES de Bakker; F Zwiers; Elke M G J de Jong
The efficacy of a new topical treatment for psoriasis: Mirak.
Journal of the European Academy of Dermatology and Venereology : JEADV 1998;11(1):13-8.
1998: M J P Gerritsen; Elke M G J de Jong; P C M van de Kerkhof
Linear lichen planopilaris of the face.
Journal of the American Academy of Dermatology 1998;38(4):633-5.
1998: JP van Pelt; Elke M G J de Jong; ES de Bakker; P C M van de Kerkhof
Effects of systemic treatment with liarozole on cutaneous inflammation, epidermal proliferation and differentiation in extensive plaque psoriasis.
Skin pharmacology and applied skin physiology 1998;11(2):70-9.
1998: CP Glade; C J M van der Vleuten; Piet E J van Erp; Elke M G J de Jong; P C M van de Kerkhof
The epidermis of chronic idiopathic lichen planus during topical treatment with the vitamin D3 analogue KH 1060.
Clinical and experimental dermatology 1998;23(1):14-8.
1998: P C M van de Kerkhof; H F Rulo; JP van Pelt; Ivonne M J J van Vlijmen-Willems; Elke M G J de Jong
Expression of endoglin in the transition between psoriatic uninvolved and involved skin.
Acta dermato-venereologica 1998;78(1):19-21.
1998: JP van Pelt; S H Kuijpers; P C M van de Kerkhof; Elke M G J de Jong
The CD11b/CD18-integrin in the pathogenesis of psoriasis.
Journal of dermatological science 1998;16(2):135-43.
1997: M M B Seyger; FH van den Hoogen; T de Boo; Elke M G J de Jong
Reliability of two methods to assess morphea: skin scoring and the use of a durometer.
Journal of the American Academy of Dermatology 1997;37(5 Pt 1):793-6.
1997: Elke M G J de Jong
The course of psoriasis.
Clinics in dermatology 1997;15(5):687-92.
1997: Elke M G J de Jong; C J M van der Vleuten; Ivonne M J J van Vlijmen-Willems
Differences in extracellular matrix proteins, epidermal growth and differentiation in discoid lupus erythematosus, lichen planus and the overlap syndrome.
Acta dermato-venereologica 1997;77(5):356-60.
1997: AL Kuijpers; Joost Schalkwijk; H F Rulo; J J Peperkamp; P C M van de Kerkhof; Elke M G J de Jong
Extremely low levels of epidermal skin-derived antileucoproteinase/elafin in a patient with impetigo herpetiformis.
The British journal of dermatology 1997;137(1):123-9.
1997: M M B Seyger; JP van Pelt; Jacob Van Den Born; MA Latijnhouwers; Elke M G J de Jong
Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.
Archives of dermatological research 1997;289(6):331-6.
1997: JP van Pelt; Elke M G J de Jong; Piet E J van Erp; M I Mitchell; P Marder; SM Spaethe; Candida A E M van Hooijdonk; AL Kuijpers; P C M van de Kerkhof
The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111).
Biochemical pharmacology 1997;53(7):1005-12.
1997: M J P Gerritsen; M E Elbers; Elke M G J de Jong; P C M van de Kerkhof
Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin.
Journal of dermatological science 1997;14(3):179-88.
1997: M M B Seyger; Jacob Van Den Born; J Schalkwijk; P C M van de Kerkhof; Elke M G J de Jong
Altered distribution of heparan sulfate proteoglycans in psoriasis.
Acta dermato-venereologica 1997;77(2):105-9.
1996: C J M van der Vleuten; Elke M G J de Jong; P C M van de Kerkhof
Epidermal differentiation characteristics of the psoriatic plaque during short contact treatment with dithranol cream.
Clinical and experimental dermatology 1996;21(6):409-14.
1996: P C M van de Kerkhof; M J P Gerritsen; Elke M G J de Jong
Transition from symptomless to lesional psoriatic skin.
Clinical and experimental dermatology 1996;21(5):325-9.
1996: C J M van der Vleuten; M J P Gerritsen; Elke M G J de Jong; M Elbers; Gys J de Jongh; P C M van de Kerkhof
A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris.
Acta dermato-venereologica 1996;76(5):387-91.
1996: C J M van der Vleuten; E J Kroot; Elke M G J de Jong; P C M van de Kerkhof
The immunohistochemical effects of a single challenge with an intermediate dose of ultraviolet B on normal human skin.
Archives of dermatological research 1996;288(9):510-6.
1996: C J M van der Vleuten; Elke M G J de Jong; P C M van de Kerkhof
Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol.
Archives of dermatological research 1996;288(7):366-72.
1996: Elke M G J de Jong; P C M van de Kerkhof
Coexistence of palmoplantar lichen planus and lupus erythematosus with response to treatment using acitretin.
The British journal of dermatology 1996;134(3):538-41.
1996: C J M van der Vleuten; C G Snijders; Elke M G J de Jong; P C M van de Kerkhof
Effects of calcipotriol and clobetasol-17-propionate on UVB-irradiated human skin: an immunohistochemical study.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1996;9(6):355-65.
1996: Elke M G J de Jong; B A Seegers; M K Gulinck; Jan B M Boezeman; P C M van de Kerkhof
Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients.
Dermatology (Basel, Switzerland) 1996;193(4):300-3.
1996: C J M van der Vleuten; M J P Gerritsen; P M Steijlen; Elke M G J de Jong; P C M van de Kerkhof
A therapeutic approach to erythrodermic psoriasis: report of a case and a discussion of therapeutic options.
Acta dermato-venereologica 1996;76(1):65-7.
1995: F H van den Hoogen; Elke M G J de Jong
Clinical aspects of systemic and localized scleroderma.
Current opinion in rheumatology 1995;7(6):546-50.
1995: Elke M G J de Jong; C M Ferrier; A de Zwart; P J Wauben-Penris; Cees Korstanje; P C M van de Kerkhof
Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis.
Journal of dermatological science 1995;9(3):185-94.
1993: P C M van de Kerkhof; Elke M G J de Jong; W P Arnold; S de Mare; C W Hol
[Vitamin D 3 analogs, e new therapy for psoriasis].
Nederlands tijdschrift voor geneeskunde 1993;137(5):232-6.
1992: Elke M G J de Jong; Piet E J van Erp; I M van Vlijmen; P C M van de Kerkhof
The inter-relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene-B4--an immunohistochemical study.
Clinical and experimental dermatology 1992;17(6):413-20.
1992: R Bischoff; Elke M G J de Jong; H F Rulo; E Sendagorta; B M Czarnetzki; P C M van de Kerkhof
Topical application of 13-cis-retinoic acid in the treatment of chronic plaque psoriasis.
Clinical and experimental dermatology 1992;17(1):9-12.
1992: A J de Zwart; Elke M G J de Jong; P C M van de Kerkhof
Topical application of dithranol on normal skin induces epidermal hyperproliferation and increased Ks8.12 binding.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1992;5(1):34-40.
1991: Elke M G J de Jong; Piet E J van Erp; D J Ruiter; P C M van de Kerkhof
Immunohistochemical detection of proliferation and differentiation in discoid lupus erythematosus.
Journal of the American Academy of Dermatology 1991;25(6 Pt 1):1032-8.
1991: Elke M G J de Jong; I M van Vlijmen; Piet E J van Erp; F C Ramaekers; S M Troyanovski; P C M van de Kerkhof
Keratin 17: a useful marker in anti-psoriatic therapies.
Archives of dermatological research 1991;283(7):480-2.
1991: Elke M G J de Jong; I M van Vlijmen; J C Scholte; A Buntinx; B Friedman; Wesley Tanaka; P C M van de Kerkhof
Clinical and biochemical effects of an oral leukotriene biosynthesis inhibitor (MK886) in psoriasis.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1991;4(4):278-85.